Literature DB >> 11034940

Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha(IIb)beta(3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets.

M T Santos1, A Moscardó, J Vallés, M Martínez, M Piñón, J Aznar, M J Broekman, A J Marcus.   

Abstract

BACKGROUND: Fibrinogen binding to the active conformation of the alpha(IIb)beta(3) integrin receptor (glycoprotein IIb/IIIa) and cytoskeletal reorganization are important events in platelet function. Tyrosine phosphorylation of platelet proteins plays an essential role in platelet signal transduction pathways. We studied the participation of tyrosine kinases on these aspects of platelet reactivity and their importance in cyclooxygenase (COX)-1-independent mechanisms in thrombin-stimulated human platelets. METHODS AND
RESULTS: Using washed platelets from normal donors and tyrphostin-A47 and aspirin as tyrosine kinase and COX-1 inhibitors, respectively, we found that tyrphostin-A47 downregulated (1) the thrombin-activated conformational change of alpha(IIb)beta(3), (2) actin polymerization and cytoskeletal reorganization, and (3) the quantity of tyrosine-phospho-rylated proteins associated with the reorganized cytoskeleton. The latter are important components of multimolecular signaling complexes. Concomitantly, platelet aggregation and secretion were significantly reduced. Aspirin did not affect receptor activation or tyrosine phosphorylation but did decrease the initial (30-second) burst of actin polymerization. Importantly, aspirin significantly amplified the inhibitory effect of tyrphostin-A47 on all aspects of platelet reactivity that we evaluated.
CONCLUSIONS: Tyrosine protein phosphorylation is a regulatory control system of the inside-out mechanism of alpha(IIb)beta(3) activation and cytoskeletal assembly in thrombin-stimulated human platelets. Inhibition of these aspects of platelet function with tyrphostin-A47 is amplified when platelets are treated with aspirin. Therefore, tyrosine phosphorylation is a major component of early signaling events and of COX-1-independent mechanisms of thrombin-induced platelet reactivity. The study results may indicate a novel target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034940     DOI: 10.1161/01.cir.102.16.1924

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

Review 1.  Platelet genomics and proteomics in human health and disease.

Authors:  Iain C Macaulay; Philippa Carr; Arief Gusnanto; Willem H Ouwehand; Des Fitzgerald; Nicholas A Watkins
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein Aggregation.

Authors:  Srinivas Ayyadevara; Meenakshisundaram Balasubramaniam; Samuel Kakraba; Ramani Alla; Jawahar L Mehta; Robert J Shmookler Reis
Journal:  Antioxid Redox Signal       Date:  2017-06-28       Impact factor: 8.401

3.  Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease.

Authors:  M Teresa Santos; Juana Vallés; Justo Aznar; Aida Lago; Elena Sanchez; Juan Cosin; Antonio Moscardó; Marta Piñón; M Johan Broekman; Aaron J Marcus
Journal:  J Lab Clin Med       Date:  2006-05

4.  Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin.

Authors:  Pavel Májek; Zuzana Reicheltová; Jana Stikarová; Jiří Suttnar; Alžběta Sobotková; Jan E Dyr
Journal:  Proteome Sci       Date:  2010-11-12       Impact factor: 2.480

5.  Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation.

Authors:  Elena Y Senchenkova; Junaid Ansari; Felix Becker; Shantel A Vital; Zaki Al-Yafeai; Erica M Sparkenbaugh; Rafal Pawlinski; Karen Y Stokes; Jennifer L Carroll; Ana-Maria Dragoi; Cheng Xue Qin; Rebecca H Ritchie; Hai Sun; Hugo H Cuellar-Saenz; Mara R Rubinstein; Yiping W Han; A Wayne Orr; Mauro Perretti; D Neil Granger; Felicity N E Gavins
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.